NCT02373371 2025-07-29
Actinic Keratoses Treatment With Metvix® in Combination With Light
University Hospital, Limoges
Phase 3 Completed
Clinical Trials
23 trialsNCT03909646 2025-05-06
BOWTIE
Maastricht University Medical Center
Phase 4 Completed
NCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT00472043 2024-08-06
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
Galderma R&D
Phase 3 Completed
NCT05725213 2024-02-23
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
Galderma Laboratorium GmbH
Completed
NCT05522036 2023-10-18
Dermaris-35
Centre Dermatologique du Roy
Phase NA Completed
NCT02144077 2022-11-03
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00535080 2021-02-18
Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Galderma R&D
No longer available
NCT01475071 2021-02-18
CoMet
Galderma R&D
Phase 3 Completed
NCT03511326 2021-02-18
SESAME 2
Galderma R&D
Phase 4 Completed
NCT02674048 2021-02-17
SESAME
Galderma R&D
Completed
NCT02464709 2019-08-28
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Joint Authority for Päijät-Häme Social and Health Care
Phase 4 Completed
NCT02367547 2019-03-28
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Unknown
NCT03012009 2018-01-25
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
University Hospital, Ghent
Phase NA Completed
NCT01482104 2017-10-27
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Norwegian University of Science and Technology
Phase NA Completed
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT02799069 2017-04-28
Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT03013647 2017-01-06
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
University of Sao Paulo General Hospital
Phase NA Unknown
NCT02149342 2016-07-11
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Completed
NCT01491711 2014-01-31
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
Maastricht University Medical Center
Phase 4 Unknown
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00369018 2010-11-30
A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.
Photocure
Phase 1/2 Completed
NCT00711178 2010-11-02
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
Bispebjerg Hospital
Phase NA Completed